These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35853510)

  • 41. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of the development of acute kidney injury following cardiac surgery by machine learning.
    Tseng PY; Chen YT; Wang CH; Chiu KM; Peng YS; Hsu SP; Chen KL; Yang CY; Lee OK
    Crit Care; 2020 Jul; 24(1):478. PubMed ID: 32736589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
    Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
    Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
    Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1987 Feb; 33(2 Pt 1):243-7. PubMed ID: 3802507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous determination of oxalate and citrate in urine and serum of calcium oxalate kidney stone rats by IP-RP LC-MS/MS.
    Li W; Zheng J; Chen M; Liu B; Liu Z; Gong L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1208():123395. PubMed ID: 35940058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early warning of citric acid overdose and timely adjustment of regional citrate anticoagulation based on machine learning methods.
    Chen H; Ma Y; Hong N; Wang H; Su L; Liu C; He J; Jiang H; Long Y; Zhu W
    BMC Med Inform Decis Mak; 2021 Jul; 21(Suppl 2):126. PubMed ID: 34330247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative Mineralogical Composition of Calculi and Urine Abnormalities for Calcium Oxalate Stone Formers: A Single-Center Results.
    Kustov AV; Strelnikov AI
    Urol J; 2018 May; 15(3):87-91. PubMed ID: 29277881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic.
    Schwille PO; Scholz D; Schwille K; Leutschaft R; Goldberg I; Sigel A
    Nephron; 1982; 31(3):194-202. PubMed ID: 7121665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-Dimensional Texture Analysis with Machine Learning Provides Incremental Predictive Information for Successful Shock Wave Lithotripsy in Patients with Kidney Stones.
    Mannil M; von Spiczak J; Hermanns T; Poyet C; Alkadhi H; Fankhauser CD
    J Urol; 2018 Oct; 200(4):829-836. PubMed ID: 29673945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic evaluation of patients with recurrent, multiple or bilateral renal stones in Jaffna.
    Rajendra S
    Ceylon Med J; 2020 Sep; 65(3):56-61. PubMed ID: 34800932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 24-h uric acid excretion and the risk of kidney stones.
    Curhan GC; Taylor EN
    Kidney Int; 2008 Feb; 73(4):489-96. PubMed ID: 18059457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.